According to Future Market Insights research, during the projected period, the global veterinary sutures market is expected to grow at a CAGR of 3.8%. The market value is projected to increase from US$ 333.38 Million in 2023 to US$ 482.1 Million by 2033. The veterinary sutures market was valued at US$ 323.0 Million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 3.2% in 2023.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 323.00 Million |
| Market Value 2023 | US$ 333.38 Million |
| Market Value 2033 | US$ 482.10 Million |
| CAGR 2023 to 2033 | 3.8% |
| Share of Top 5 Countries | 57.5% |
| Key Players | B. Braun; Ethicon; Medtronic Plc; Betatech Medical; Changzhou Zener Medtec; Gamastech; Génia; KATSAN Medical Devices; RWD Life Science; Somni Scientific; CP Medical; Vetersut; Vitrex Medical; AIP Medical SA; Oasis; GPC Medical Ltd; AdvaCare Pharma; Cortis |
An injury/wound in animals may results in a break, tear, or damage to the skin or underlying tissues. Wounds can be caused due to several factors, which includes overcrowding in animals, animal bites, climate changes, surgical procedures, or infections disorders in animals. The veterinary sutures are used to close wounds or incisions in animals. There are mainly two types of veterinary sutures - absorbable suture and non-absorbable suture. The types of sutures that veterinarians may use, depends on the location, size, and type of tissue being repaired.
The absorbable sutures are typically used for internal wounds or incisions, during surgeries of the internal organs, muscles, or other tissues. Non-absorbable sutures are made from materials like such as nylon, silk, or steel. They are typically used for wounds or incisions that require long-term support, such as skin lacerations, or for the repair of tendons or ligaments.
Overall, the increasing pet ownership rate, advancements in suture material and greater awareness of the benefits of wound closure with sutures is likely due to their convenience, efficacy, and safety, which is likely to boost the market in the coming years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of the veterinary sutures market grew at a CAGR of 2.4% between 2015 to 2022. Veterinary sutures market contributes 7.5% revenue share to the global surgical sutures market value at around US$ 4.3 Billion in 2022.
There has been a significant increase in pet adoption around the world in recent years. With the rising social media activities and increased access to information, there has been a growing awareness of animal welfare issues around the world. This has led people adopt pets from animal shelters and rescue organizations, rather than buying from breeders or pet stores.
There are several studies have shown that owning a pet can have a positive impact on human health the reason includes reducing stress, improving mental health, and increasing physical activity. This has led to an increase in the number of people seeking to adopt pets as companion animals.
Many animal shelters and rescue organizations now hold adoption events and campaigns to encourage pet adoption. These events often feature reduced adoption fees, education on responsible pet ownership, and opportunities to meet and interact with pets.
Hence, with increasing pet adoption the chances of injuries and wounds in their pets is also increasing with different factors including outdoor activities, lack of supervision on pets, health conditions of pets.
Considering this, FMI expects the global veterinary sutures market to grow at a CAGR of 3.8% through the forecasted years.
Minimally invasive surgical procedures are becoming more popular in veterinary medicine. Minimally invasive procedures require smaller incisions than traditional surgeries, which can reduce pain and discomfort for the animal and speed up the recovery process. Due to the incisions are smaller, the risk of infection is also lower than with traditional surgeries.
The development of new suturing materials for veterinary surgical procedures has the potential to improve the outcomes of surgical procedures by providing better wound healing and reducing the risk of infection. In addition, expansion of veterinary services in developing regions is crucial to improving animal health and welfare, as well as public health and food security.
In many developing regions, there is a lack of access to veterinary services, which can lead to the spread of diseases, poor animal welfare, and reduced productivity in the agricultural sector. Thus providing training and education to local veterinary professionals, increasing use of telemedicine, engaging with local communities and building trust can help increase the uptake of veterinary services and improve animal health and welfare.
Hence, due to increasing adoption of minimally invasive surgeries, development of new and innovative raw materials for suture manufacturing and expansion of veterinary services in developing regions is ultimately creating opportunities for veterinary suture market.
Principal Consultant
As the market for veterinary sutures is smaller than the human medical market, and the volume of sutures required for veterinary procedures is typically lower than for human procedures, there are a limited number of manufacturers that specialize in veterinary suture manufacturing.
The limited number of manufacturers in the veterinary suture market does create some challenges for both manufacturers and customers. For manufacturers, it can be difficult to compete in a relatively small market, and there may be limited opportunities for growth or expansion. For customers, limited options can make it more difficult to find the exact products they need or to negotiate favourable pricing.
These factors are expected to hamper revenue growth of the global market over the forecast period.
The USA dominated the global market in 2022 and is expected to register a CAGR of 3.0% during the forecast period.
The United States has the most advanced veterinary care in the world, with a large number of specialized veterinary clinics and hospitals that offer a wide range of surgical procedures. This advanced level of care often requires the use of specialized veterinary sutures, which contributes to the higher demand for these products in the United States. Also, the United States has a well-established distribution network for veterinary products, including sutures. This makes it easier for manufacturers to distribute their products to veterinary clinics and hospitals across the country.
The demand for veterinary sutures will increase due to high prevalence, which will drive the expansion of the market.
Russia dominated the European market for veterinary sutures and accounted for around 31.4% of the market share in 2022.
Russia has a relatively large pet population among all the European countries this large pet population creates a significant demand for veterinary care and surgical procedures, including the use of veterinary sutures. Also, the Russian government has implemented various policies and initiatives aimed at improving animal welfare and promoting pet ownership. This support for the pet industry has also contributed to the growth of the veterinary care industry and the demand for veterinary sutures.
Hence, Russia holds the dominant share and continue to do so over the forecasted period.
China is projected to be the most attractive market for veterinary sutures, and is expected to grow over a significant CAGR of 6.4% over the forecast period.
In some parts of China, traditional medicine practices may be used for treating animal wounds instead of modern veterinary medicine. While these practices may have cultural significance, they may not be as effective in treating animal wounds as modern veterinary medicine.
Due to such factors, in China, there is increasing number of wounds and injuries of animals and the proper treatments and medication will be required which sets the China as an emerging market for veterinary sutures.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The absorbable suture segment held the major chunk of about 61.7% in global market by the end of 2022.
The absorbable sutures do not require removal after the incision has healed, which can be challenging in animals that may resist restraint or require anesthesia to remove sutures. Additionally, the use of absorbable sutures eliminates the need for a follow-up appointment for suture removal, reducing the overall cost and inconvenience to the owner.
Also, absorbable sutures are less likely to cause tissue reactions, such as inflammation, infection, or rejection, which can delay wound healing and increase the risk of complications. This is especially important in veterinary surgeries, where animals may be more prone to infection due to their outdoor or unsanitary living conditions.
Due to such facts, the absorbable sutures are preferred over non-absorbable sutures in veterinary surgeries.
The Polyglactin absorbable surgical sutures segment held the market share of about 23.3% in global market by the end of 2022.
The polyglactin is a synthetic polymer that is made from glycolide and lactide monomers, which break down in the body over time and are absorbed by the body's natural processes. There excellent handling characteristics of polyglactin sutures includes they are easy to work with, and have a smooth, non-lifting surface, which reduces the risk of tissue irritation and infection. Polyglactin sutures are also available in a range of sizes and lengths, making them suitable for use in various surgical procedures and in animals of different sizes.
The excellent handling characteristics, low inflammatory response, availability of different sizes and lengths, and cost-effectiveness make Polyglactin sutures a popular choice for veterinary surgeons in various surgical procedures.
The veterinary hospitals segment accounted for revenue share of 41.4% in the global market at the end of 2022.
The veterinary hospitals tend to see more emergency cases, which may require more sutures to address acute injuries or wounds. This may lead to a higher use of sutures in veterinary hospitals compared to veterinary clinics, which tend to focus more on routine procedures such as vaccinations, check-ups, and minor surgeries.
Hence, due to higher complexity and volume of surgical cases that handle by veterinary hospitals, as well as their larger staff and inventory of surgical supplies they holds maximum market share in veterinary services market.
Key players in the market are focused on increase their product portfolio to strengthen their position in the veterinary suture market, and to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain competitive edge in the market are invests heavily in research and development to create new products and technologies, actively expansion of their presence in emerging markets, joint ventures and partnership agreements.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the veterinary sutures market space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2015 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East; and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Russia, BENELUX, Nordics, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Türkiye, South Africa, North Africa, and GCC Countries |
| Key Segments Covered | Treatment, Distribution Channel, and Region |
| Key Companies Profiled | B. Braun; Ethicon; Medtronic Plc; Betatech Medical; Changzhou Zener Medtec; Gamastech; Génia; KATSAN Medical Devices; RWD Life Science; Somni Scientific; CP Medical; Vetersut; Vitrex Medical; AIP Medical SA; Oasis; GPC Medical Ltd; AdvaCare Pharma; Cortis |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is estimated to reach US$ 482.1 million by 2033.
Somni Scientific, CP Medical, and Vetersut are the key market players.
The market is estimated to secure a valuation of US$ 333.38 million in 2023.
The growth potential of the market is 3.8% through 2033.
Advancements in suture material drive sales.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption Analysis by Region
4.2. Reimbursement Scenario
4.3. New Product Launches & Approvals
4.4. Regulatory Scenario
4.5. PESTLE Analysis
4.6. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Spending Outlook
5.1.3. Parent Market Analysis (Surgical Sutures Market)
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Healthcare Spending
5.2.2. Increasing Number of Wound & Injuries in Animals
5.2.3. Greater Demand for Minimally Invasive Procedures
5.2.4. Increasing Initiatives by Manufacturers to Educate the General Population
5.2.5. Increasing Pet Adoption Rate
5.2.6. Key companies are focusing on novel product developments and launches
5.2.7. Availability of Products
5.2.8. Stringent Regulatory Policies
5.2.9. COVID-19 Impact
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Suture Type
6.1.2. By Raw Material
6.1.3. By End User
6.1.4. By Region
6.2. Pre COVID-19 & Post COVID-19 Impact Analysis
6.3. 2022 Market Scenario
7. Global Market Demand (in Value or Size in US$ Million) Analysis 2015 to 2022 and Forecast, 2023 to 2033
7.1. Revenue Opportunity Scenario
7.2. Historical Market Value (US$ Million) Analysis 2015 to 2022
7.3. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
7.3.1. Y-o-Y Growth Trend Analysis
7.3.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Suture Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Suture Type, 2015 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Suture Type, 2023 to 2033
8.3.1. Absorbable Sutures
8.3.2. Non-Absorbable Sutures
8.4. Market Attractiveness Analysis By Suture Type
9. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Raw Material
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Raw Material, 2015 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Raw Material, 2023 to 2033
9.3.1. Catgut Absorbable Surgical Sutures
9.3.2. Polyglactin Absorbable Surgical Sutures
9.3.3. Poliglecaprone Absorbable Surgical Sutures
9.3.4. Polydioxanone Absorbable Surgical Sutures
9.3.5. Polyglycolic Acid Absorbable Surgical Sutures
9.3.6. Silk Non-Absorbable Surgical Sutures
9.3.7. Nylon (poylamide) Non-Absorbable Surgical Sutures
9.3.8. Polypropylene Non-Absorbable Surgical Sutures
9.3.9. Stainless Steel Non-Absorbable Surgical Sutures
9.3.10. Others
9.4. Market Attractiveness Analysis By Raw Material
10. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By End User
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
10.3.1. Veterinary Hospitals
10.3.2. Veterinary Clinics
10.3.3. Academic & Research Institutes
10.4. Market Attractiveness Analysis By End User
11. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Region
11.1. Introduction
11.2. Historical Market Value (US$ Million) Analysis By Region, 2015 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Region, 2023 to 2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East & Africa
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2015 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2015 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
12.3.1. By Country
12.3.1.1. USA
12.3.1.2. Canada
12.3.2. By Suture Type
12.3.3. By Raw Material
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Suture Type
12.4.3. By Raw Material
12.4.4. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country-Level Analysis & Forecast
12.8.1. USA Market
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Suture Type
12.8.1.2.2. By Raw Material
12.8.1.2.3. By End User
12.8.2. Canada Market
12.8.3. Introduction
12.8.4. Market Analysis and Forecast by Market Taxonomy
12.8.4.1.1. By Suture Type
12.8.4.1.2. By Raw Material
12.8.4.1.3. By End User
13. Latin America Market Analysis 2015 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2015 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Suture Type
13.3.3. By Raw Material
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Suture Type
13.4.3. By Raw Material
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. Brazil Market
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Suture Type
13.8.1.2.2. By Raw Material
13.8.1.2.3. By End User
13.8.2. Mexico Market
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Suture Type
13.8.2.2.2. By Raw Material
13.8.2.2.3. By End User
13.8.3. Argentina Market
13.8.4. Introduction
13.8.5. Market Analysis and Forecast by Market Taxonomy
13.8.5.1.1. By Suture Type
13.8.5.1.2. By Raw Material
13.8.5.1.3. By End User
14. Europe Market Analysis 2015 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2015 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. UK
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Suture Type
14.3.3. By Raw Material
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Suture Type
14.4.3. By Raw Material
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Germany Market
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Suture Type
14.8.1.2.2. By Raw Material
14.8.1.2.3. By End User
14.8.2. Italy Market
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Suture Type
14.8.2.2.2. By Raw Material
14.8.2.2.3. By End User
14.8.3. France Market
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Suture Type
14.8.3.2.2. By Raw Material
14.8.3.2.3. By End User
14.8.4. UK Market
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Suture Type
14.8.4.2.2. By Raw Material
14.8.4.2.3. By End User
14.8.5. Spain Market
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast by Market Taxonomy
14.8.5.2.1. By Suture Type
14.8.5.2.2. By Raw Material
14.8.5.2.3. By End User
14.8.6. BENELUX Market
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast by Market Taxonomy
14.8.6.2.1. By Suture Type
14.8.6.2.2. By Raw Material
14.8.6.2.3. By End User
14.8.7. Russia Market
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast by Market Taxonomy
14.8.7.2.1. By Suture Type
14.8.7.2.2. By Raw Material
14.8.7.2.3. By End User
15. East Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2015 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Suture Type
15.3.3. By Raw Material
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Suture Type
15.4.3. By Raw Material
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. China Market
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Suture Type
15.8.1.2.2. By Raw Material
15.8.1.2.3. By End User
15.8.2. Japan Market
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Suture Type
15.8.2.2.2. By Raw Material
15.8.2.2.3. By End User
15.8.3. South Korea Market
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Suture Type
15.8.3.2.2. By Raw Material
15.8.3.2.3. By End User
16. South Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2015 to 2022
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Suture Type
16.3.3. By Raw Material
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Suture Type
16.4.3. By Raw Material
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Market
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Suture Type
16.8.1.2.2. By Raw Material
16.8.1.2.3. By End User
16.8.2. Indonesia Market
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Suture Type
16.8.2.2.2. By Raw Material
16.8.2.2.3. By End User
16.8.3. Malaysia Treatment Market
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Suture Type
16.8.3.2.2. By Raw Material
16.8.3.2.3. By End User
16.8.4. Thailand Market
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Suture Type
16.8.4.2.2. By Raw Material
16.8.4.2.3. By End User
17. Oceania Market Analysis 2015 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2015 to 2022
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Suture Type
17.3.3. By Raw Material
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Suture Type
17.4.3. By Raw Material
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. Australia Treatment Market
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Suture Type
17.8.1.2.2. By Raw Material
17.8.1.2.3. By End User
17.8.2. New Zealand Treatment Market
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Suture Type
17.8.2.2.2. By Raw Material
17.8.2.2.3. By End User
18. Middle East and Africa Market Analysis 2015 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2015 to 2022
18.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Türkiye
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Suture Type
18.3.3. By Raw Material
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Suture Type
18.4.3. By Raw Material
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. GCC Countries Market
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Suture Type
18.8.1.2.2. By Raw Material
18.8.1.2.3. By End User
18.8.2. Türkiye Market
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Suture Type
18.8.2.2.2. By Raw Material
18.8.2.2.3. By End User
18.8.3. South Africa Market
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Suture Type
18.8.3.2.2. By Raw Material
18.8.3.2.3. By End User
18.8.4. North Africa Market
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Suture Type
18.8.4.2.2. By Raw Material
18.8.4.2.3. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis (%) of Top Players
19.3. Market Presence Analysis
19.3.1. Regional Footprint of Players
19.3.2. Product Footprint of Players
19.3.3. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Benchmarking
20.2. Promotional and Branding Strategies by Manufacturers
20.3. Competition Dashboard
20.4. Competition Deep Dive
20.4.1. B. Braun Vet Care GmbH
20.4.1.1. Overview
20.4.1.2. Treatment Portfolio
20.4.1.3. Sales Footprint
20.4.1.4. Key Financials
20.4.1.5. SWOT Analysis
20.4.1.6. Strategy Overview
20.4.1.6.1. Marketing Strategy
20.4.1.6.2. Product Strategy
20.4.1.6.3. Channel Strategy
20.4.2. Ethicon, Inc. (Johnson & Johnson)
20.4.2.1. Overview
20.4.2.2. Treatment Portfolio
20.4.2.3. Sales Footprint
20.4.2.4. Key Financials
20.4.2.5. SWOT Analysis
20.4.2.6. Strategy Overview
20.4.2.6.1. Marketing Strategy
20.4.2.6.2. Product Strategy
20.4.2.6.3. Channel Strategy
20.4.3. Medtronic Plc
20.4.3.1. Overview
20.4.3.2. Treatment Portfolio
20.4.3.3. Sales Footprint
20.4.3.4. Key Financials
20.4.3.5. SWOT Analysis
20.4.3.6. Strategy Overview
20.4.3.6.1. Marketing Strategy
20.4.3.6.2. Product Strategy
20.4.3.6.3. Channel Strategy
20.4.4. Betatech Medical
20.4.4.1. Overview
20.4.4.2. Treatment Portfolio
20.4.4.3. Sales Footprint
20.4.4.4. Key Financials
20.4.4.5. SWOT Analysis
20.4.4.6. Strategy Overview
20.4.4.6.1. Marketing Strategy
20.4.4.6.2. Product Strategy
20.4.4.6.3. Channel Strategy
20.4.5. Changzhou Zener Medtec
20.4.5.1. Overview
20.4.5.2. Treatment Portfolio
20.4.5.3. Sales Footprint
20.4.5.4. Key Financials
20.4.5.5. SWOT Analysis
20.4.5.6. Strategy Overview
20.4.5.6.1. Marketing Strategy
20.4.5.6.2. Product Strategy
20.4.5.6.3. Channel Strategy
20.4.6. Gamastech
20.4.6.1. Overview
20.4.6.2. Treatment Portfolio
20.4.6.3. Sales Footprint
20.4.6.4. Key Financials
20.4.6.5. SWOT Analysis
20.4.6.6. Strategy Overview
20.4.6.6.1. Marketing Strategy
20.4.6.6.2. Product Strategy
20.4.6.6.3. Channel Strategy
20.4.7. Génia
20.4.7.1. Overview
20.4.7.2. Treatment Portfolio
20.4.7.3. Sales Footprint
20.4.7.4. Key Financials
20.4.7.5. SWOT Analysis
20.4.7.6. Strategy Overview
20.4.7.6.1. Marketing Strategy
20.4.7.6.2. Product Strategy
20.4.7.6.3. Channel Strategy
20.4.8. KATSAN Medical Devices
20.4.8.1. Overview
20.4.8.2. Treatment Portfolio
20.4.8.3. Sales Footprint
20.4.8.4. Key Financials
20.4.8.5. SWOT Analysis
20.4.8.6. Strategy Overview
20.4.8.6.1. Marketing Strategy
20.4.8.6.2. Product Strategy
20.4.8.6.3. Channel Strategy
20.4.9. RWD Life Science
20.4.9.1. Overview
20.4.9.2. Treatment Portfolio
20.4.9.3. Sales Footprint
20.4.9.4. Key Financials
20.4.9.5. SWOT Analysis
20.4.9.6. Strategy Overview
20.4.9.6.1. Marketing Strategy
20.4.9.6.2. Product Strategy
20.4.9.6.3. Channel Strategy
20.4.10. SoMillioni Scientific
20.4.10.1. Overview
20.4.10.2. Treatment Portfolio
20.4.10.3. Sales Footprint
20.4.10.4. Key Financials
20.4.10.5. SWOT Analysis
20.4.10.6. Strategy Overview
20.4.10.6.1. Marketing Strategy
20.4.10.6.2. Product Strategy
20.4.10.6.3. Channel Strategy
20.4.11. CP Medical
20.4.11.1. Overview
20.4.11.2. Treatment Portfolio
20.4.11.3. Sales Footprint
20.4.11.4. Key Financials
20.4.11.5. SWOT Analysis
20.4.11.6. Strategy Overview
20.4.11.6.1. Marketing Strategy
20.4.11.6.2. Product Strategy
20.4.11.6.3. Channel Strategy
20.4.12. Vetersut
20.4.12.1. Overview
20.4.12.2. Treatment Portfolio
20.4.12.3. Sales Footprint
20.4.12.4. Key Financials
20.4.12.5. SWOT Analysis
20.4.12.6. Strategy Overview
20.4.12.6.1. Marketing Strategy
20.4.12.6.2. Product Strategy
20.4.12.6.3. Channel Strategy
20.4.13. Vitrex Medical
20.4.13.1. Overview
20.4.13.2. Treatment Portfolio
20.4.13.3. Sales Footprint
20.4.13.4. Key Financials
20.4.13.5. SWOT Analysis
20.4.13.6. Strategy Overview
20.4.13.6.1. Marketing Strategy
20.4.13.6.2. Product Strategy
20.4.13.6.3. Channel Strategy
20.4.14. AIP Medical SA
20.4.14.1. Overview
20.4.14.2. Treatment Portfolio
20.4.14.3. Sales Footprint
20.4.14.4. Key Financials
20.4.14.5. SWOT Analysis
20.4.14.6. Strategy Overview
20.4.14.6.1. Marketing Strategy
20.4.14.6.2. Product Strategy
20.4.14.6.3. Channel Strategy
20.4.15. Oasis
20.4.15.1. Overview
20.4.15.2. Treatment Portfolio
20.4.15.3. Sales Footprint
20.4.15.4. Key Financials
20.4.15.5. SWOT Analysis
20.4.15.6. Strategy Overview
20.4.15.6.1. Marketing Strategy
20.4.15.6.2. Product Strategy
20.4.15.6.3. Channel Strategy
20.4.16. GPC Medical Ltd
20.4.16.1. Overview
20.4.16.2. Treatment Portfolio
20.4.16.3. Sales Footprint
20.4.16.4. Key Financials
20.4.16.5. SWOT Analysis
20.4.16.6. Strategy Overview
20.4.16.6.1. Marketing Strategy
20.4.16.6.2. Product Strategy
20.4.16.6.3. Channel Strategy
20.4.17. AdvaCare Pharma
20.4.17.1. Overview
20.4.17.2. Treatment Portfolio
20.4.17.3. Sales Footprint
20.4.17.4. Key Financials
20.4.17.5. SWOT Analysis
20.4.17.6. Strategy Overview
20.4.17.6.1. Marketing Strategy
20.4.17.6.2. Product Strategy
20.4.17.6.3. Channel Strategy
20.4.18. Cortis
20.4.18.1. Overview
20.4.18.2. Treatment Portfolio
20.4.18.3. Sales Footprint
20.4.18.4. Key Financials
20.4.18.5. SWOT Analysis
20.4.18.6. Strategy Overview
20.4.18.6.1. Marketing Strategy
20.4.18.6.2. Product Strategy
20.4.18.6.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Veterinary Sutures Market
